The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Yukio Homma

Department of Urology

Graduate School of Medicine

The University of Tokyo

Tokyo

Japan

[email]@umin.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 2002 - 2011

References

  1. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Homma, Y., Kakizaki, H., Yamaguchi, O., Yamanishi, T., Nishizawa, O., Yokoyama, O., Takeda, M., Seki, N., Yoshida, M. Urology (2011) [Pubmed]
  2. Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Homma, Y., Kawabe, K., Takeda, M., Yoshida, M. Urology (2010) [Pubmed]
  3. Editorial Comment to Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. Homma, Y. Int. J. Urol. (2010) [Pubmed]
  4. A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder. Homma, Y., Yamaguchi, O. Int. J. Urol. (2009) [Pubmed]
  5. Clinical guideline for male lower urinary tract symptoms. Homma, Y., Araki, I., Igawa, Y., Ozono, S., Gotoh, M., Yamanishi, T., Yokoyama, O., Yoshida, M. Int. J. Urol. (2009) [Pubmed]
  6. Symptom severity and patient perceptions in overactive bladder: how are they related? Homma, Y., Gotoh, M. BJU Int. (2009) [Pubmed]
  7. Should an antimuscarinic agent be used for persistent LUTS after treatment with an alpha(1)-blocker?. Homma, Y. Nature Clinical Practice. Urology (2009) [Pubmed]
  8. Japanese guideline for diagnosis and treatment of interstitial cystitis. Homma, Y., Ueda, T., Ito, T., Takei, M., Tomoe, H. Int. J. Urol. (2009) [Pubmed]
  9. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Homma, Y., Ueda, T., Tomoe, H., Lin, A.T., Kuo, H.C., Lee, M.H., Lee, J.G., Kim, D.Y., Lee, K.S. Int. J. Urol. (2009) [Pubmed]
  10. Long-term safety, tolerability, and efficacy of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder. Homma, Y., Yamaguchi, O. Int. J. Urol. (2008) [Pubmed]
  11. Core Lower Urinary Tract Symptom score (CLSS) questionnaire: a reliable tool in the overall assessment of lower urinary tract symptoms. Homma, Y., Yoshida, M., Yamanishi, T., Gotoh, M. Int. J. Urol. (2008) [Pubmed]
  12. Lower urinary tract symptomatology: Its definition and confusion. Homma, Y. Int. J. Urol. (2008) [Pubmed]
  13. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Homma, Y., Yoshida, M., Seki, N., Yokoyama, O., Kakizaki, H., Gotoh, M., Yamanishi, T., Yamaguchi, O., Takeda, M., Nishizawa, O. Urology (2006) [Pubmed]
  14. Epidemiologic survey of lower urinary tract symptoms in Japan. Homma, Y., Yamaguchi, O., Hayashi, K. Urology (2006) [Pubmed]
  15. Classification of nocturia in the adult and elderly patient: a review of clinical criteria and selected literature. Homma, Y. BJU Int. (2005) [Pubmed]
  16. An epidemiological survey of overactive bladder symptoms in Japan. Homma, Y., Yamaguchi, O., Hayashi, K. BJU Int. (2005) [Pubmed]
  17. Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate. Homma, Y., Kondo, Y., Kaneko, M., Kitamura, T., Nyou, W.T., Yanagisawa, M., Yamamoto, Y., Kakizoe, T. Carcinogenesis (2004) [Pubmed]
  18. Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer. Homma, Y., Akaza, H., Okada, K., Yokoyama, M., Usami, M., Hirao, Y., Tsushima, T., Sakamoto, A., Ohashi, Y., Aso, Y. Int. J. Urol. (2004) [Pubmed]
  19. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results. Homma, Y., Akaza, H., Okada, K., Yokoyama, M., Moriyama, N., Usami, M., Hirao, Y., Tsushima, T., Sakamoto, A., Ohashi, Y., Aso, Y. Int. J. Urol. (2004) [Pubmed]
  20. Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial. Homma, Y., Kawabe, K. World. J. Urol (2004) [Pubmed]
  21. Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial. Homma, Y., Paick, J.S., Lee, J.G., Kawabe, K. BJU Int. (2003) [Pubmed]
  22. Voiding and incontinence frequencies: variability of diary data and required diary length. Homma, Y., Ando, T., Yoshida, M., Kageyama, S., Takei, M., Kimoto, K., Ishizuka, O., Gotoh, M., Hashimoto, T. Neurourol. Urodyn. (2002) [Pubmed]
 
WikiGenes - Universities